Meclizine Hydrochloride
- Product NDC
- 68071-2416
- 11-digit product format
- 680712416
- Labeler code
- 68071
- Product ID
- 68071-2416_4e0616b9-e78e-896d-e063-6294a90a7e9c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Meclizine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- NDA010721
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2020-01-15
- Substance
- MECLIZINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antiemetic [EPC], Emesis Suppression [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N010721-001 | ANTIVERT | MECLIZINE HYDROCHLORIDE | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD, RS | 1982-01-20 |
| N010721-004 | ANTIVERT | MECLIZINE HYDROCHLORIDE | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD, Approved before 1982 | |
| N010721-005 | ANTIVERT | MECLIZINE HYDROCHLORIDE | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, CHEWABLE / ORAL | RLD, RS, Approved before 1982 | ||
| N010721-006 | ANTIVERT | MECLIZINE HYDROCHLORIDE | 12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD, Approved before 1982 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N010721-001 | AA |
| N010721-004 | AA |
| N010721-006 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N010721-001 | ANTIVERT | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD, RS | 1982-01-20 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N010721-004 | ANTIVERT | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD, Approved before 1982 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N010721-005 | ANTIVERT | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, CHEWABLE / ORAL | RLD, RS, Approved before 1982 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N010721-006 | ANTIVERT | 12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD, Approved before 1982 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N010721-001 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N010721-004 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N010721-006 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | St. Mary's Medical Park Pharmacy | c6b3f4d8-5fcf-2278-e053-2a95a90ab139 | 2026-06-21 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | d7d31433-8f39-4fe6-b542-1b4410122db7 | 2026-06-12 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Bryant Ranch Prepack | 81e1762b-e012-4c6d-96e6-9a9f27a1880a | 2026-05-27 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | REMEDYREPACK INC. | 21d4a6ee-0a66-45d7-bab9-c5eef399713d | 2026-05-13 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | REMEDYREPACK INC. | d53bf04e-5cfc-4974-9b24-2cce545d1bd0 | 2026-04-15 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | c31846b2-d47d-a97b-e053-2a95a90a9bec | 2026-03-27 | Warnings, Adverse reactions | 010721 NDA010721 68071-2416 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | beb36d86-9fb7-1f60-e053-2995a90aac13 | 2026-03-02 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Bryant Ranch Prepack | 112103bc-25e2-42cf-8542-ba1d3392a2c3 | 2025-08-20 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Bryant Ranch Prepack | 27b6a7e0-a361-4705-9f31-719063a65f22 | 2025-08-20 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | c9ddc39c-bc6b-42f1-8c5f-5aff2d79c4bd | 2025-06-02 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 2d31ae73-3f09-a77c-e063-6294a90ade9a | 2025-02-02 | Warnings, Adverse reactions | 010721 NDA010721 |
| MECLIZINE HYDROCHLORIDE | MECLIZINE HYDROCHLORIDE | DirectRx | d27fe828-4fee-3ba9-e053-2995a90ae7b6 | 2025-01-20 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Proficient Rx LP | 92e8390b-5173-4aa1-906d-35d2c0eaaaf6 | 2024-08-01 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Direct_Rx | e79ecf77-0e0a-d7ef-e053-2a95a90a5adf | 2024-04-09 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Asclemed USA, Inc. | e6a5df4b-5cbf-4a0c-b38a-f4509c9c17db | 2024-04-08 | Warnings, Adverse reactions | 010721 NDA010721 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Proficient Rx LP | b91435d1-fb95-4939-8478-84e41f44f732 | 2023-04-01 | Warnings, Adverse reactions | 010721 NDA010721 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Meclizine Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MECLIZINE HYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| HDP7W44CIO | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995666 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| c31846b2-d47d-a97b-e053-2a95a90a9bec | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-2416-6 | 2023-01-30 | C162847 | 48780-1 | f386c64a-38cc-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MECLIZINE HYDROCHLORIDE safely and effectively. See full prescribing information for MECLIZINE HYDROCHLORIDE. MECLIZINE hydrochloride tablets, for oral use MECLIZINE hydrochloride chewable tablets, for oral use Initial U.S. Approval: 1957 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-2416-6 | Meclizine Hydrochloride | 6 in 1 BOTTLE | TABLET | 6 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-2416 | MECLIZINE HYDROCHLORIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20210525_c31846b2-d47d-a97b-e053-2a95a90a9bec.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995666 | meclizine HCl 25 MG Oral Tablet | PSN | c31846b2-d47d-a97b-e053-2a95a90a9bec | 2 |
| 995666 | meclizine hydrochloride 25 MG Oral Tablet | SCD | c31846b2-d47d-a97b-e053-2a95a90a9bec | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-2416-6 | 68071241606 | 6 TABLET in 1 BOTTLE (68071-2416-6) | 6 tablet | 2021-05-24 | 0000-00-00 | No | No | Current |